T1	Pharmacological_substance 10 19	Bleomycin
N1000 	Reference T1 MeSH:D001761	Bleomycin
N1001 	Reference T1 MeSH:C047120	Bleomycin
T2	Disorder 28 45	hyperpigmentation
N1 	Reference T2 UMLS:C0162834	hyperpigmentation
T3	Disorder 51 65	yolk sac tumor
N2 	Reference T3 UMLS:C0014145	yolk sac tumor
T6	Disorder 68 85	Hyperpigmentation
N3 	Reference T6 UMLS:C0162834	Hyperpigmentation
T7	Disorder 224 238	yolk sac tumor
N4 	Reference T7 UMLS:C0014145	yolk sac tumor
T9	Pharmacological_substance 337 346	cisplatin
N1002 	Reference T9 MeSH:D002945	cisplatin
T10	Pharmacological_substance 348 357	etoposide
N1003 	Reference T10 MeSH:D005047	etoposide
T11	Pharmacological_substance 362 371	bleomycin
N1004 	Reference T11 MeSH:D001761	bleomycin
N1005 	Reference T11 MeSH:C047120	bleomycin
T12	Disorder 377 394	hyperpigmentation
N5 	Reference T12 UMLS:C0162834	hyperpigmentation
T13	Disorder 501 514	skin toxicity
T14	Pharmacological_substance 518 527	bleomycin
N1006 	Reference T14 MeSH:D001761	bleomycin
N1007 	Reference T14 MeSH:C047120	bleomycin
T15	Pharmacological_substance 126 149	chemotherapautic agents
N1008 	Reference T15 MeSH:D000970	chemotherapautic agents
N1009 	Reference T15 MeSH:D000970	chemotherapautic agents
T16	Subject 213 218	child
T18	Disorder 253 275	localized pigmentation
